Bioscience

Medipacs

March 22, 2010

By Flinn Foundation

[Source: San Diego Business Journal] – The drug delivery device market is expected to increase to $16.7 billion by 2012, from $11.8 billion in 2007, according to a study released in late 2009 by Massachusetts-based global management consulting firm Scientia Advisors, and one San Diego-based company is positioned to become a major player in the industry.

Medipacs Inc., founded in Tucson, Ariz., in 2004, has invented and developed a “revolutionary drug delivery device,” basically a disposable infusion pump that can be programmed to slowly deliver small volumes of drugs for several days at a time, or for one, singular dose.

The Medipacs pump, which has yet to be named, is the first non-mechanical infusion pump to use a new, expandable polymer. The Medipacs novel polymer pump is wearable, increasing a patient’s comfort and convenience, Medipacs Chief Executive Officer Mark McWilliams said.

For more information: Medipacs’ Polymer Technology Positions Firm for Long-Term Growth